Ignite Creation Date:
2025-12-25 @ 2:52 AM
Ignite Modification Date:
2026-03-01 @ 6:00 AM
Study NCT ID:
NCT02999633
Status:
TERMINATED
Last Update Posted:
2022-03-21
First Post:
2016-12-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-03-08
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-19
First Submit QC Date:
None
Study First Post Date:
2016-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-10
Results First Submit QC Date:
None
Results First Post Date:
2020-01-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2018-11-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-03-10
Last Update Post Date:
2022-03-21
Last Update Post Date Type:
ACTUAL